Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Jui-Wen Kang"'
Autor:
Jui-Wen Kang, Po-Jun Chen, Chiung-Yu Chen, Guillermo Riley, Yao-Sheng Wang, Hsin-Yu Kuo, Chiao-Hsiung Chuang
Publikováno v:
Endoscopy International Open, Vol 11, Iss 11, Pp E1026-E1034 (2023)
Externí odkaz:
https://doaj.org/article/ad9de4082b0740798db8c2a63f322372
Publikováno v:
Journal of the Formosan Medical Association, Vol 121, Iss 1, Pp 402-408 (2022)
Background: Fecal immunochemical test (FIT) is worldwide strategy for colorectal cancer screening. The subjects with negative FIT still have the risk of an advanced colorectal neoplasia (AN), including adenoma with villous histology, high grade dyspl
Externí odkaz:
https://doaj.org/article/a6a8f0ec6d9e42308d6b89831381db42
Autor:
Yan-Shen Shan, Li-Tzong Chen, Jin-Shang Wu, Yin-Fan Chang, Chih-Ting Lee, Chih-Hsing Wu, Nai-Jung Chiang, Hsin-En Huang, Chia-Jui Yen, Ying-Jui Chao, Hui-Jen Tsai, Chiung-Yu Chen, Jui-Wen Kang, Chin-Fu Kuo, Chia-Rung Tsai, Ya-Ling Weng, Han-Chien Yang, Hui-Chin Liu, Jeffrey S. Chang
Publikováno v:
Journal of Biomedical Science, Vol 27, Iss 1, Pp 1-14 (2020)
Abstract Background Due to differences in genetic background, it is unclear whether the genetic loci identified by the previous genome-wide association studies (GWAS) of pancreatic cancer also play significant roles in the development of pancreatic c
Externí odkaz:
https://doaj.org/article/84665822d70547ba90bd5cbed0aec83a
Autor:
Yi-Sheng Liu, Xi-Zhang Lin, Chiung-Yu Chen, Yen-Cheng Chiu, Jui-Wen Kang, Hung-Wen Tsai, Hui-Yu Hung, Chi-Ming Ho, Ming-Ching Ou
Publikováno v:
Biomolecules & Biomedicine, Vol 21, Iss 3 (2021)
Transarterial chemoembolization (TACE) is, currently, the recommended treatment for hepatocellular carcinoma (HCC). However, long-term chemoembolization triggers the inflammatory response and may lead to postembolization syndrome (PES). Although seve
Externí odkaz:
https://doaj.org/article/3f315a67310746fb9da752b388d242cc
Autor:
Chiao-Hsiung Chuang, Chien-Cheng Chen, Jhong-Han Wu, Ming-Yuan Hong, Jui-Wen Kang, Hsin-Yu Kuo, Chien-Jui Huang, Chiung-Yu Chen
Publikováno v:
Endoscopy International Open, Vol 08, Iss 12, Pp E1811-E1816 (2020)
Background and study aims Early detection of upper gastrointestinal (UGI) rebleeding is not easy by observing clinical symptoms. We developed a novel UGI monitoring system and aimed to test its feasibility of continuous tracking of UGI bleeding. Pati
Externí odkaz:
https://doaj.org/article/1316af56dc5549a6bc05a128d709b53c
Publikováno v:
World Journal of Clinical Cases. 10:12430-12439
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4489abbff0217a90dc88d0fbbe0c779b
https://doi.org/10.12998/wjcc.v10.i33.12430
https://doi.org/10.12998/wjcc.v10.i33.12430
Publikováno v:
Digestive Diseases and Sciences. 67:5239-5247
Endoscopic sphincterotomy (EST), endoscopic papillary balloon dilation (EPBD), and endoscopic sphincterotomy plus balloon dilation (ESBD) are all techniques used to manage choledocholithiasis. We aim to analyze the efficacy and safety of these techni
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1091d0f1b496a8f5064e0418d3ad64d8
https://doi.org/10.1007/s10620-021-07360-0
https://doi.org/10.1007/s10620-021-07360-0
Publikováno v:
Frontline Gastroenterology; Sep2024, Vol. 15 Issue 5, p434-435, 2p
Autor:
Bing-Syuan Chung, I-Chuang Liao, Peng-Chan Lin, Shang-Yin Wu, Jui-Wen Kang, Bo-Wen Lin, Po-Chuan Chen, Ren-Hao Chan, Chung-Ta Lee, Meng-Ru Shen, Shang-Hung Chen, Yu-Min Yeh
Publikováno v:
International Journal of Molecular Sciences; Volume 23; Issue 21; Pages: 13277
Programmed death-ligand 1 (PD-L1) is an immune checkpoint molecule that can regulate immune responses in the tumor microenvironment (TME); however, the clinical applications of PD-L1 in early-stage colorectal cancer (CRC) remain unclear. In this stud
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a5b91e67c944a0f3a14d62baec9ac4d
https://pubmed.ncbi.nlm.nih.gov/36362062
https://pubmed.ncbi.nlm.nih.gov/36362062
Autor:
Shih-Chieh Chien, Chiung Yu Chen, Hong Ming Tsai, I-Chin Wu, Chiao-Hsiung Chuang, Yih Jyh Lin, Hsin-Yu Kuo, Hung-Chih Chiu, Pin-Nan Cheng, Po-Jun Chen, Ting-Tsung Chang, Meng-Zhi Han, Jui-Wen Kang, Yen-Cheng Chiu
Publikováno v:
Cancer Immunology, Immunotherapy
Programmed cell death protein-1 (PD-1) inhibitors have shown promising results for treating advanced hepatocellular carcinoma (HCC). However, the clinical utility of such inhibitors in HCC patients with vascular tumor thrombosis remains unclear. This
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1405859d7c1bb99522aa1521ed39baf
https://doi.org/10.1007/s00262-020-02845-9
https://doi.org/10.1007/s00262-020-02845-9